Evidence map›Paper›PMID 25071831›Full record

ArticleFrontiers in genetics2014

A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons.

Kevin Machino, Christopher D Link, Susan Wang, Hana Murakami, Shin Murakami

Abstract read
In one paragraph

Article in Frontiers in genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Discovery of TDP-43 aggregation inhibitorsbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. eNeuro · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Frailty andFrontiers in nutrition · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kevin MachinoDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California Vallejo, CA, USA.
Christopher D LinkInstitute of Behavioral Genetics, University of Colorado, Boulder Boulder, CO, USA.
Susan WangDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California Vallejo, CA, USA.
Hana MurakamiDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California Vallejo, CA, USA.
Shin MurakamiDepartment of Basic Sciences, College of Osteopathic Medicine, Touro University California Vallejo, CA, USA.

Funding

TRANSGENIC C. ELEGANS AS AMYLOID DISEASE MODELR01AG012423 · NIA · UNIVERSITY OF COLORADO AT BOULDER · PI LINK, CHRISTOPHER D. · 1996 to 2012
$3.6M
NIA NIH HHS R01 AG012423
6 · The paper itself

Abstract

Multi-Worm Tracker (MWT) is a real-time computer vision system that can simultaneously quantify motional patterns of multiple worms. MWT provides several behavioral parameters, including analysis of accurate real-time locomotion speed in the nematode, Caenorhabditis elegans. Here, we determined locomotion speed of the Alzheimer's disease (AD) transgenic strain that over-expresses human beta-amyloid1-42 (Aβ) in the neurons. The MWT analysis showed that the AD strain logged a slower average speed than the wild type (WT) worms. The results may be consistent with the observation that the AD patients with dementia tend to show deficits in physical activities, including frequent falls. The AD strain showed reduced ability of the eggs to hatch and slowed hatching of the eggs. Thus, over-expression of Aβ in neurons causes negative effects on locomotion and hatchability. This study sheds light on new examples of detrimental effects that Aβ deposits can exhibit using C. elegans as a model system. The information gathered from this study indicates that the motion tracking analysis is a cost-effective, efficient way to assess the deficits of Aβ over-expression in the C. elegans system.

Indexed as

age-related memory impairment (AMI)Alzheimer's diseaseAlzheimer's disease in childrenautomated systembehavioral agingbeta amyloidfrailtymotion tracking

Identifiers

PMID25071831
PMCPMC4082091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.